期刊
EXPERT REVIEW OF VACCINES
卷 8, 期 6, 页码 729-745出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/ERV.09.30
关键词
5CVMB; meningococcal disease; outer membrane protein; outer membrane vesicle vaccine; serogroup B
类别
Serogroup B meningococci cause the majority of the meningococcal disease burden in developed countries. Production of an effective and safe vaccine for serogroup B organisms has been hampered by the poor immunogenicity of the capsular polysaccharide that defines this group of bacteria. Previous efforts have focused on outer membrane vesicle vaccines, which have been implemented successfully during clonal outbreaks. However, the search for a universal vaccine against endemic polyclonal serogroup B meningococcal disease continues. In this review, we have highlighted recent development of outer membrane vesicle vaccines and progress in the evaluation of recombinant outer membrane protein vaccines.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据